The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma

Background: The purpose of this study was to investigate whether the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can be used as supplemental tools to differentiate between uterine myomas and sarcomas. Methods: From January 2000 to May 2020, patients diagnosed with ute...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoon Young Jeong, Eun Ji Lee, Eun Byeol Cho, Jung Min Ryu, Youn Seok Choi
Format: Article
Language:English
Published: IMR Press 2021-08-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/48/4/10.31083/j.ceog4804142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170653946150912
author Yoon Young Jeong
Eun Ji Lee
Eun Byeol Cho
Jung Min Ryu
Youn Seok Choi
author_facet Yoon Young Jeong
Eun Ji Lee
Eun Byeol Cho
Jung Min Ryu
Youn Seok Choi
author_sort Yoon Young Jeong
collection DOAJ
description Background: The purpose of this study was to investigate whether the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can be used as supplemental tools to differentiate between uterine myomas and sarcomas. Methods: From January 2000 to May 2020, patients diagnosed with uterine sarcoma or myoma after surgery at the Catholic University Hospital of Daegu were enrolled in the study. The age and preoperative hematologic findings including hemoglobin, white blood cell count, neutrophils, lymphocytes, platelet counts and lactate dehydrogenase were retrospectively investigated. Results: A total of 366 patients, including 40 uterine sarcoma patients and 326 uterine myoma patients, were included in the study. Among the hematologic findings, NLR and PLR showed statistically significant differences between uterine sarcoma and myoma. The probability of sarcoma was high when NLR was ≥2.6 and PLR was ≥150.0. When NLR was ≥2.6, the odds ratio of uterine sarcoma risk was 9.761 (95% confidence interval [CI]: 3.950–24.120, P < 0.001). When PLR was ≥150, the odds ratio of uterine sarcoma risk was 3.502 (95% CI: 1.528–8.027, P = 0.003). If NLR was above their cut-offs, the sensitivity of uterine sarcoma diagnosis was 60% and specificity was 83.4%. Identically, PLR was 60% and 73.3%, respectively. Conclusion: NLR and PLR are useful supplemental tools for the differential diagnosis of uterine myoma and sarcoma. Therefore, more expensive and accurate imaging studies, such as magnetic resonance imaging, can be more effectively recommended when these hematologic findings are used together with pelvic ultrasonography.
format Article
id doaj-art-9adc49527f554580970e2bc6e79fe8ba
institution OA Journals
issn 0390-6663
language English
publishDate 2021-08-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-9adc49527f554580970e2bc6e79fe8ba2025-08-20T02:20:26ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632021-08-0148490190610.31083/j.ceog4804142S0390-6663(21)00149-4The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcomaYoon Young Jeong0Eun Ji Lee1Eun Byeol Cho2Jung Min Ryu3Youn Seok Choi4Department of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, 42472 Daegu, South KoreaDepartment of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, 42472 Daegu, South KoreaDepartment of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, 42472 Daegu, South KoreaDepartment of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, 42472 Daegu, South KoreaDepartment of Obstetrics and Gynecology, Catholic University of Daegu School of Medicine, 42472 Daegu, South KoreaBackground: The purpose of this study was to investigate whether the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can be used as supplemental tools to differentiate between uterine myomas and sarcomas. Methods: From January 2000 to May 2020, patients diagnosed with uterine sarcoma or myoma after surgery at the Catholic University Hospital of Daegu were enrolled in the study. The age and preoperative hematologic findings including hemoglobin, white blood cell count, neutrophils, lymphocytes, platelet counts and lactate dehydrogenase were retrospectively investigated. Results: A total of 366 patients, including 40 uterine sarcoma patients and 326 uterine myoma patients, were included in the study. Among the hematologic findings, NLR and PLR showed statistically significant differences between uterine sarcoma and myoma. The probability of sarcoma was high when NLR was ≥2.6 and PLR was ≥150.0. When NLR was ≥2.6, the odds ratio of uterine sarcoma risk was 9.761 (95% confidence interval [CI]: 3.950–24.120, P < 0.001). When PLR was ≥150, the odds ratio of uterine sarcoma risk was 3.502 (95% CI: 1.528–8.027, P = 0.003). If NLR was above their cut-offs, the sensitivity of uterine sarcoma diagnosis was 60% and specificity was 83.4%. Identically, PLR was 60% and 73.3%, respectively. Conclusion: NLR and PLR are useful supplemental tools for the differential diagnosis of uterine myoma and sarcoma. Therefore, more expensive and accurate imaging studies, such as magnetic resonance imaging, can be more effectively recommended when these hematologic findings are used together with pelvic ultrasonography.https://www.imrpress.com/journal/CEOG/48/4/10.31083/j.ceog4804142uterine neoplasmleiomyomauterine sarcomaneutrophil-to-lymphocyte ratio (nlr)platelet-to-lymphocyte ratio (plr)
spellingShingle Yoon Young Jeong
Eun Ji Lee
Eun Byeol Cho
Jung Min Ryu
Youn Seok Choi
The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
Clinical and Experimental Obstetrics & Gynecology
uterine neoplasm
leiomyoma
uterine sarcoma
neutrophil-to-lymphocyte ratio (nlr)
platelet-to-lymphocyte ratio (plr)
title The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
title_full The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
title_fullStr The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
title_full_unstemmed The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
title_short The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
title_sort role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma
topic uterine neoplasm
leiomyoma
uterine sarcoma
neutrophil-to-lymphocyte ratio (nlr)
platelet-to-lymphocyte ratio (plr)
url https://www.imrpress.com/journal/CEOG/48/4/10.31083/j.ceog4804142
work_keys_str_mv AT yoonyoungjeong theroleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT eunjilee theroleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT eunbyeolcho theroleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT jungminryu theroleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT younseokchoi theroleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT yoonyoungjeong roleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT eunjilee roleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT eunbyeolcho roleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT jungminryu roleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma
AT younseokchoi roleofplatelettolymphocyteratioandneutrophiltolymphocyteratioasasupplementaltoolfordifferentialdiagnosisofuterinemyomaandsarcoma